Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GGZ Friesland is a leading mental healthcare organization providing comprehensive psychiatric services in the province of Friesland, Netherlands. The institution serves a diverse patient population, including children, adolescents, adults, and the elderly, through a network of specialized clinics and outpatient centers. Their clinical focus encompasses a broad range of conditions such as depression, anxiety, personality disorders, psychosis, and addiction. In addition to direct patient care, GGZ Friesland is actively involved in scientific research and the education of future mental health professionals. The organization operates several specialized labels, including Kinnik for youth mental health and MindUp for social rehabilitation. By integrating evidence-based treatments with innovative care models, GGZ Friesland aims to improve the quality of life and mental well-being of the regional population.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GGZ Friesland.